Evogene has partnered with QUT in Australia to progress the development of AI-driven small molecule cancer therapeutics.

J&J has received the US FDA approval for a new monthly dosing schedule for the combination therapy Rybrevant Faspro to treat ...

Respondents from a GlobalData survey have identified drug pricing and reimbursement hurdles as one of the top three pharma ...

A growth in the systemic lupus erythematosus (SLE) and lupus nephritis (LN) market across the 7MM is anticipated, as per ...

Industry and US administration leaders lay out their plans to navigate a globally competitive pharma landscape with China’s growing dominance.

With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.

The UK was the highest ranked country for those offshoring pharma R&D, raising questions about its pharma industry’s attractiveness.

Teijin Pharma has signed a joint research agreement with Aska Pharmaceutical to develop small-molecule drug candidates for ...

ExCellThera, along with its wholly owned subsidiary Cordex Biologics, has received Status 1 listing from the NUB programme in ...

As theranostic radiopharmaceuticals gain prevalence, companies must overcome associated regulatory, manufacturing and ...

The FDA's verdict on PTC's Translarna could spell the end for the drug's decades-long and tumultuous US DMD development ...

Outgoing Merck KGaA CEO Belén Garijo is set take the helm at Sanofi, after the French vaccine specialist announced it would ...